Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Allergan

This article was originally published in The Tan Sheet

Executive Summary

"Positive performance in the U.S. contact lens care market" is not enough to prevent an 8.3% drop in worldwide contact lens care sales to $72.9 mil. for the first quarter, the company announces April 27. Global Consept F sales dropped 15.4% to $8.8 mil., while Complete sales increased 44.3%, reflecting "transition from multibottle oxidative systems to non-oxidative, one-bottle systems," Allergan says. Contact lens sales declined 7% to $5.6 mil. at constant currency levels. A 20.8% increase in consolidated sales to $376.2 mil. for the quarter led to a 24.3% improvement in net earnings, which reached $43.5 mil compared to the year-ago period
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS091140

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel